Jenny Mcdaniel, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Hema Biologics
    Topic:
    Hemophilia
    Date added:
    08/01/2026
    Date updated:
    08/01/2026
    Relationship end date:
    01/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Sanofi
    Topic:
    Hemophilia
    Date added:
    08/01/2026
    Date updated:
    08/01/2026
    Relationship end date:
    01/01/2026
  • Attribution:
    Self
    Type of financial relationship:
    Advisor
    Ineligible company:
    Pfizer
    Topic:
    Hemophilia
    Date added:
    08/01/2026
    Date updated:
    08/01/2026
    Relationship end date:
    01/01/2026
Return to The Next Era in Non-Factor Therapy for Hemophilia: Clinical Evidence and Practical Implications of Evolving FVIIIA Mimetics